Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Henry Schein

Is Henry Schein Stock Outperforming the Dow?

Henry Schein has outperformed the Dow over the past year, and analysts remain moderately optimistic about the stock’s prospects.

Barchart

Henry Schein's Q1 2025 Earnings: What to Expect

Henry Schein is gearing up to announce its Q1 results in the upcoming month, and analysts expect a modest increase in earnings.

Barchart

Is Henry Schein Stock Underperforming the Nasdaq?

Although Henry Schein has lagged behind the Nasdaq Composite, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s future.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Henry Schein Meets 80-Plus Relative Strength Rating Benchmark

Henry Schein shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 74 to 81.

Investors Business Daily

Henry Schein Shows Improved Relative Strength; Still Shy Of Benchmark

Henry Schein shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Is Wall Street Bullish or Bearish on Henry Schein Stock?

Henry Schein has trailed the broader market over the past year, yet analysts maintain a cautiously optimistic outlook on its future performance.

Barchart

The Analyst Verdict: Henry Schein In The Eyes Of 4 Experts

Henry Schein (NASDAQ:HSIC) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks?

Henry Schein outperformed its industry peers recently, and Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

The CEO trying to solve the dental care crisis

Stan Bergman, CEO of dental supply company Henry Schein, describes some of his efforts as “enlightened self-interest.”

Fortune

What Are Wall Street Analysts' Target Price for Henry Schein Stock?

As Henry Schein underperformed the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Why are hackers targeting healthcare providers?

An exploration of why the healthcare sector has become a target for cyber attacks

TechRadar

Henry Schein (HSIC) Q3 Earnings Analysis: A Medical Stock to Watch?

Henry Schein (HSIC) posted solid third-quarter 2023 sales growth and non-GAAP EPS growth despite continued lower sales of PPE products and COVID-19 test kits. In addition, the company’s long-term outlook appears bright, driven by sustained demand for its healthcare solutions and strategic investments. So, is it worth adding this medical…

StockNews.com

Markets Today: Stock Index Futures Edge Lower as U.S. Shutdown Risks Linger

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.21%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.27%. Stock index futures this morning are moderately lower. Stocks are also under pressure this morning after Moody’s Investors Service late Friday cut its outlook on the U.S....

Barchart

BlackCat strikes again - and this time it's breached a healthcare giant

Henry Schein is the latest victim of a ransomware attack, but it seems as if it paid its attackers.

TechRadar

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stocks Retreat as Hawkish Fed Comments Push Bond Yields Higher

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.32%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed down -0.67%. Stock indexes on Friday gave up early gains and...

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022

Upgrades

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Henry Schein's Return On Capital Employed Overview

Pulled from Benzinga Pro data, Henry Schein (NASDAQ:HSIC) posted Q1 earnings of $186.00 million, an increase from Q4 of 22.25%. Sales dropped to $3.18 billion, a 4.56% decrease between quarters.

Benzinga

Henry Schein Q1 Earnings Beat Street View, Sticks To FY22 Guidance

Henry Schein Inc (NASDAQ:HSIC) posts Q1 FY22 sales of $3.32 billion, beating the consensus of $3.13 billion, up 8.7% Y/Y, including 7.7% internal growth in local currencies, 2.4% growth from acquisitions, and a 1.4% decline related to foreign currency exchange. Q4 internal sales growth in local currencies, excluding personal protective equipment and COVID-19…

Benzinga

Recap: Henry Schein Q1 Earnings

Henry Schein (NASDAQ:HSIC) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Henry Schein Earnings Conference Call Is Coming Up, Here's What You Need To Know

Henry Schein (NASDAQ:HSIC) will host a conference call at 10:00 AM ET on May 3, 2022, to discuss Q1 2022 earnings results. How to Attend Henry Schein (HSIC) Conference Call Follow this link to access the live webcast.

Benzinga

Henry Schein Earnings Perspective: Return On Invested Capital

According to Benzinga Pro data Henry Schein (NASDAQ:HSIC) posted a 10.22% decrease in earnings from Q3. Sales, however, increased by 4.81% over the previous quarter to $3.33 billion.

Benzinga

Henry Schein Q4 Topline, Bottom Line Beat Street View, FY22 Outlook Exceeds Consensus

Henry Schein Inc (NASDAQ: HSIC) posts

Benzinga

Henry Schein: Q4 Earnings Insights

Henry Schein (NASDAQ:HSIC) reported its Q4 earnings results on Tuesday, February 15, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

1 2

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Dow Jones Industrials

262 stories

Raymond James

257 stories

Palantir Technologies

245 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.